IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ERNEST C VON HARTEN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1154950194
CMS profile
11426240
Location
ST PETERSBURG, FL

General Payments · PY2022–2024

$1,404.18

  • Reported across 65 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,084.57

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family Medicine FL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,084.57 54

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $197.60 9
Acerta Pharma LLC $184.74 8
Exact Sciences Corporation $107.21 5
Amgen Inc. $85.78 5
Novo Nordisk AS $82.13 5
Lilly USA, LLC $71.59 3
GlaxoSmithKline, LLC. $64.80 3
PFIZER INC. $54.95 3
Takeda Pharmaceuticals U.S.A., Inc. $42.72 3
Phathom Pharmaceuticals, Inc. $40.58 1
Dynavax Technologies Corporation $34.56 2
Salix Pharmaceuticals, a division of Bausch Health US, LLC $33.89 2
Daiichi Sankyo Inc. $20.36 1
Bayer HealthCare Pharmaceuticals Inc. $17.70 1
NOVARTIS PHARMACEUTICALS CORPORATION $16.45 1
Merck Sharp & Dohme Corporation $16.01 1
Currax Pharmaceuticals LLC $13.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $143.00 2
PY2023 $176.61 9
PY2024 $1,084.57 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.46 02/07/2024 Food and Beverage Undisputed 01/23/2026 1106291804 CMS
ABBVIE INC. $34.44 04/19/2024 Food and Beverage Undisputed 01/23/2026 1106291806 CMS
ABBVIE INC. $24.88 05/22/2024 Food and Beverage Undisputed 01/23/2026 1106291808 CMS
ABBVIE INC. $22.02 06/04/2024 Food and Beverage Undisputed 01/23/2026 1106291810 CMS
ABBVIE INC. $32.55 08/12/2024 Food and Beverage Undisputed 01/23/2026 1106291812 CMS
ABBVIE INC. $12.18 08/20/2024 Food and Beverage Undisputed 01/23/2026 1106291814 CMS
ABBVIE INC. $15.78 09/16/2024 Food and Beverage Undisputed 01/23/2026 1106291816 CMS
ABBVIE INC. $12.58 10/16/2024 Food and Beverage Undisputed 01/23/2026 1106291818 CMS
ABBVIE INC. $25.71 10/30/2024 Food and Beverage Undisputed 01/23/2026 1106291820 CMS
Amgen Inc. $21.18 06/17/2024 Food and Beverage Undisputed 01/23/2026 1117408263 CMS
Amgen Inc. $13.50 07/16/2024 Food and Beverage Undisputed 01/23/2026 1117408265 CMS
Amgen Inc. $21.94 08/07/2024 Food and Beverage Undisputed 01/23/2026 1111734565 CMS
Amgen Inc. $14.46 10/15/2024 Food and Beverage Undisputed 01/23/2026 1111734567 CMS
Amgen Inc. $14.70 11/14/2024 Food and Beverage Undisputed 01/23/2026 1111734569 CMS
AstraZeneca Pharmaceuticals LP $16.47 01/29/2024 Food and Beverage Undisputed 01/23/2026 1104266337 CMS
AstraZeneca Pharmaceuticals LP $71.18 02/27/2024 Food and Beverage Undisputed 01/23/2026 1104475722 CMS
AstraZeneca Pharmaceuticals LP $15.34 04/24/2024 Food and Beverage Undisputed 01/23/2026 1104756356 CMS
AstraZeneca Pharmaceuticals LP $18.90 05/29/2024 Food and Beverage Undisputed 01/23/2026 1104629730 CMS
AstraZeneca Pharmaceuticals LP $18.90 06/24/2024 Food and Beverage Undisputed 01/23/2026 1104312284 CMS
AstraZeneca Pharmaceuticals LP $14.97 07/31/2024 Food and Beverage Undisputed 01/23/2026 1105561266 CMS
AstraZeneca Pharmaceuticals LP $15.03 10/28/2024 Food and Beverage Undisputed 01/23/2026 1105482909 CMS
AstraZeneca Pharmaceuticals LP $13.95 11/19/2024 Food and Beverage Undisputed 01/23/2026 1104421483 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.70 11/12/2024 Food and Beverage Undisputed 01/23/2026 1086200720 CMS
Currax Pharmaceuticals LLC $13.50 11/11/2024 Food and Beverage Undisputed 01/23/2026 1089510708 CMS
Daiichi Sankyo Inc. $20.36 07/22/2024 Food and Beverage Undisputed 01/23/2026 1089495452 CMS
Dynavax Technologies Corporation $16.04 09/23/2024 Food and Beverage Undisputed 01/23/2026 1082152073 CMS
Dynavax Technologies Corporation $18.52 12/09/2024 Food and Beverage Undisputed 01/23/2026 1082153879 CMS
Exact Sciences Corporation $16.57 02/15/2024 Food and Beverage Undisputed 01/23/2026 1114434979 CMS
Exact Sciences Corporation $24.99 05/28/2024 Food and Beverage Undisputed 01/23/2026 1114434983 CMS
Exact Sciences Corporation $21.07 08/02/2024 Food and Beverage Undisputed 01/23/2026 1114434987 CMS
Exact Sciences Corporation $25.20 10/14/2024 Food and Beverage Undisputed 01/23/2026 1114434991 CMS
Exact Sciences Corporation $19.38 12/12/2024 Food and Beverage Undisputed 01/23/2026 1114434995 CMS
GlaxoSmithKline, LLC. $27.04 05/14/2024 Food and Beverage Undisputed 01/23/2026 1116389118 CMS
GlaxoSmithKline, LLC. $17.15 07/05/2024 Food and Beverage Undisputed 01/23/2026 1116682379 CMS
GlaxoSmithKline, LLC. $20.61 09/13/2024 Food and Beverage Undisputed 01/23/2026 1115786762 CMS
Lilly USA, LLC $25.20 01/30/2024 Food and Beverage Undisputed 01/23/2026 1134974347 CMS
Lilly USA, LLC $23.77 05/07/2024 Food and Beverage Undisputed 01/23/2026 1134969465 CMS
Lilly USA, LLC $22.62 11/07/2024 Food and Beverage Undisputed 01/23/2026 1136171570 CMS
Merck Sharp & Dohme LLC $16.01 07/23/2024 Food and Beverage Undisputed 01/23/2026 1141803605 CMS
Novartis Pharmaceuticals Corporation $16.45 09/10/2024 Food and Beverage Undisputed 01/23/2026 1087437706 CMS
Novo Nordisk Inc $18.35 01/10/2024 Food and Beverage Undisputed 01/23/2026 1096801975 CMS
Novo Nordisk Inc $14.64 02/12/2024 Food and Beverage Undisputed 01/23/2026 1097338809 CMS
Novo Nordisk Inc $16.02 05/01/2024 Food and Beverage Undisputed 01/23/2026 1097363030 CMS
Novo Nordisk Inc $17.00 08/22/2024 Food and Beverage Undisputed 01/23/2026 1096984931 CMS
Novo Nordisk Inc $16.12 12/16/2024 Food and Beverage Undisputed 01/23/2026 1097513824 CMS
PFIZER INC. $14.97 03/06/2024 Food and Beverage Undisputed 01/23/2026 1131223789 CMS
PFIZER INC. $26.12 11/18/2024 Food and Beverage Undisputed 01/23/2026 1131084486 CMS
PFIZER INC. $13.86 12/11/2024 Food and Beverage Undisputed 01/23/2026 1131197214 CMS
Phathom Pharmaceuticals, Inc. $40.58 08/14/2024 Food and Beverage Undisputed 01/23/2026 1151136907 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.38 08/03/2024 Food and Beverage Undisputed 01/23/2026 1153656329 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.51 09/21/2024 Food and Beverage Undisputed 01/23/2026 1153552945 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.43 01/17/2024 Food and Beverage Undisputed 01/23/2026 1137693384 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.44 04/17/2024 Food and Beverage Undisputed 01/23/2026 1137693386 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.85 07/17/2024 Food and Beverage Undisputed 01/23/2026 1137693388 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.